Pharma partnering: other people’s science

Partnering with Big Pharma—What Academics Need to Know

Knowledge of the parameters of drug development can greatly aid academic scientists hoping to partner with pharmaceutical companies. Here, we discuss the three major pillars of drug development-pharmacodynamics, pharmacokinetics, and toxicity studies-which, in addition to pre-clinical efficacy, are critical for partnering with Big Pharma to produce novel therapeutics.

Advantage, Pharma: Partnering Earlier in the Development Cycle Ocular Injections & Beyond: Impact of Silicone Oil a Polymer Pfs for Minimising Risk of Protein Oxidation

Putting the “Co” in Development and Promotion

While collaborations between emerging biotechnology companies and pharma/biopharma companies are not new, these deals dramatically have increased in sheer number and deal value. Perhaps the most important recent trend to note is a structural one—a trend away from the conventional royalty model toward 50/50 cost and profit sharing collaborations. Last year, even small, emerging biotech companies...

From Cold War Science Diplomacy to Partnering in a Networked World: 30 Years of Sino-us Relations in Science and Technology

January 31, 2009 marked the 30 anniversary of the signing of the Agreement Between the Governments of the People’s Republic of China and the United States of America on Cooperation in Science and Technology (hereafter, the Agreement). The signing marked the formalization of reestablished ties in science and technology between the two countries which began following the signing of the Shanghai C...

A credit period contract towards coordination of pharmaceutical supply chain:The case of inventory-level-dependent demand

This paper considers a two stages pharmaceutical supply chain (PSC) consisting of a pharmaceutical manufacturer (pharma-manufacturer) that supplies one type of pharmaceutical product to a pharma-retailer. The customer demand rate for the pharmaceutical product is dependent on the pharma-retailer’s current-inventory level. The pharma-retailer determines the order quantity ( ) value as decision v...